PGGM Investments’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,102
| Closed | -$1.17M | – | 346 |
|
|
2024
Q1 | $1.17M | Sell |
4,102
-5,315
| -56% | -$1.56M | 0.02% | 294 |
|
|
2023
Q4 | $2.71M | Hold |
9,417
| – | – | 0.04% | 247 |
|
|
2023
Q3 | $2.53M | Sell |
9,417
-7,414
| -44% | -$1.85M | 0.04% | 252 |
|
|
2023
Q2 | $3.74M | Sell |
16,831
-37,821
| -69% | -$8.78M | 0.06% | 230 |
|
|
2023
Q1 | $13.2M | Sell |
54,652
-20,401
| -27% | -$5.01M | 0.22% | 81 |
|
|
2022
Q4 | $19.7M | Sell |
75,053
-19,520
| -21% | -$5.23M | 0.35% | 55 |
|
|
2022
Q3 | $21.3M | Buy |
+94,573
| New | +$22.9M | 0.37% | 54 |
|
|
2022
Q1 | $37.6M | Hold |
167,211
| – | – | 0.19% | 121 |
|
|
2021
Q4 | $37.6M | Buy |
167,211
+5,918
| +4% | +$1.25M | 0.19% | 121 |
|
|
2021
Q3 | $34.3M | Buy |
161,293
+42,281
| +36% | +$9.73M | 0.18% | 144 |
|
|
2021
Q2 | $29M | Sell |
119,012
-73,187
| -38% | -$18M | 0.12% | 178 |
|
|
2021
Q1 | $47.8M | Sell |
192,199
-92,360
| -32% | -$22M | 0.21% | 105 |
|
|
2020
Q4 | $65.4M | Sell |
284,559
-217,931
| -43% | -$50.2M | 0.3% | 70 |
|
|
2020
Q3 | $128M | Hold |
502,490
| – | – | 0.67% | 46 |
|
|
2020
Q2 | $119M | Buy |
502,490
+847
| +0.2% | +$193K | 0.69% | 44 |
|
|
2020
Q1 | $102M | Sell |
501,643
-4,614
| -0.9% | -$1.01M | 0.73% | 44 |
|
|
2019
Q4 | $122M | Sell |
506,257
-389,877
| -44% | -$85.9M | 0.69% | 43 |
|
|
2019
Q3 | $173M | Hold |
896,134
| – | – | 0.83% | 37 |
|
|
2019
Q2 | $165M | Hold |
896,134
| – | – | 0.83% | 37 |
|
|
2019
Q1 | $170M | Hold |
896,134
| – | – | 0.87% | 35 |
|
|
2018
Q4 | $174M | Hold |
896,134
| – | – | 1.01% | 25 |
|
|
2018
Q3 | $186M | Hold |
896,134
| – | – | 0.98% | 24 |
|
|
2018
Q2 | $165M | Buy |
896,134
+264,941
| +42% | +$46.9M | 0.91% | 25 |
|
|
2018
Q1 | $108M | Buy |
631,193
+99,093
| +19% | +$18.2M | 0.61% | 42 |
|
|
2017
Q4 | $92.5M | Sell |
532,100
-174,528
| -25% | -$30.9M | 0.52% | 50 |
|
|
2017
Q3 | $132M | Buy |
706,628
+35,692
| +5% | +$6.32M | 0.65% | 37 |
|
|
2017
Q2 | $116M | Buy |
670,936
+15,059
| +2% | +$2.45M | 0.59% | 43 |
|
|
2017
Q1 | $108M | Sell |
655,877
-41,412
| -6% | -$6.88M | 0.56% | 43 |
|
|
2016
Q4 | $102M | Sell |
697,289
-24,097
| -3% | -$3.63M | 0.52% | 42 |
|
|
2016
Q3 | $120M | Sell |
721,386
-4,298
| -0.6% | -$727K | 0.6% | 42 |
|
|
2016
Q2 | $110M | Buy |
725,684
+64,011
| +10% | +$9.95M | 0.56% | 45 |
|
|
2016
Q1 | $99.2M | Buy |
661,673
+9,308
| +1% | +$1.38M | 0.53% | 49 |
|
|
2015
Q4 | $106M | Sell |
652,365
-106,397
| -14% | -$16.7M | 0.56% | 51 |
|
|
2015
Q3 | $105M | Buy |
758,762
+4,060
| +0.5% | +$640K | 0.57% | 50 |
|
|
2015
Q2 | $116M | Buy |
754,702
+659,798
| +695% | +$106M | 0.6% | 46 |
|
|
2015
Q1 | $15.2M | Buy |
+94,904
| New | +$14.9M | 0.07% | 293 |
|
|
2014
Q4 | – | Sell |
-309,265
| Closed | -$43.4M | – | 371 |
|
|
2014
Q3 | $43.4M | Buy |
309,265
+9,788
| +3% | +$1.28M | 0.21% | 106 |
|
|
2014
Q2 | $35.4M | Buy |
+299,477
| New | +$34.7M | 0.17% | 130 |
|
|
2014
Q1 | – | Sell |
-672,457
| Closed | -$76.8M | – | 369 |
|
|
2013
Q4 | $76.8M | Sell |
672,457
-11,358
| -2% | -$1.29M | 0.42% | 58 |
|
|
2013
Q3 | $76.5M | Buy |
683,815
+11,699
| +2% | +$1.27M | 0.45% | 56 |
|
|
2013
Q2 | $66.3M | Buy |
+672,116
| New | +$69.7M | 0.39% | 67 |
|
Other funds holding AMGN
PGGM Investments's AMGN Position: Q2 2024 in Review
PGGM Investments sold out of Amgen (AMGN) in Q2 2024, closing a stake of 4,102 shares — an estimated $1.17M sold.
PGGM Investments first reported a position in AMGN in Q2 2013 and held it in 41 quarters. The position peaked at $186M in Q3 2018. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- PGGM Investments reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
- PGGM Investments sold 4,102 Amgen shares in Q2 2024, an estimated $1.17M.
- PGGM Investments first reported a position in Amgen in Q2 2013 and held it in 41 quarters.
- PGGM Investments's Amgen position peaked at $186M in Q3 2018.
- 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on PGGM Investments's 13F filing for Q2 2024, filed 16 Jul 2024.